# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-002209
Filing Date
2024-04-25
Accepted
2024-04-25 06:02:07
Documents
9
Period of Report
2024-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | f6k_042424.htm | 6-K | 34301
2 | GRAPHIC | articles_01.jpg | GRAPHIC | 88224
3 | GRAPHIC | articles_02.jpg | GRAPHIC | 26264
4 | GRAPHIC | articles_03.jpg | GRAPHIC | 121449
5 | GRAPHIC | articles_04.jpg | GRAPHIC | 136055
6 | GRAPHIC | articles_05.jpg | GRAPHIC | 123748
7 | GRAPHIC | articles_06.jpg | GRAPHIC | 135038
8 | GRAPHIC | articles_07.jpg | GRAPHIC | 116425
9 | GRAPHIC | articles_08.jpg | GRAPHIC | 50975
| Complete submission text file | 0001171843-24-002209.txt |  | 1131475

Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-82318 | Film No.: 24872665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)